Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 05.01.2021       PNE AG

DGAP-Media / 05.01.2021 / 10:29 Press release PNE AG has brokered further power purchase agreements (PPA) for operators Cuxhaven, January 5, 2021 - PNE AG has again further expanded its positioning in the brokerage business of power purchase agreements (PPAs) in 2020. With an additional volume of around 300 gigawatt hours (GWh), PNE was ab [ … ]
Tue, 05.01.2021       Atriva Therapeutics GmbH

Atriva Therapeutics obtains approval from German authorities for Phase II trial in COVID-19 patients, led by Charité Clinic in Berlin - RESPIRE is a placebo-controlled, international, multi-center trial treating hospitalized patients with moderate to severe COVID-19 - The Phase II clinical trial will evaluate efficacy, safety and pharmacokinetics [ … ]
Tue, 05.01.2021       Nouveau Monde Graphite

MONTRÉAL, QUÉBEC, January 5, 2020 - Nouveau Monde Graphite Inc. ("Nouveau Monde" or the "Company") (TSX.V: NOU; OTCQX: NMGRF; Frankfurt: NM9) is starting 2021 with momentum after a remarkably productive fall season. The Company expects to obtain governmental authorization for its Matawinie graphite project early in Q1, enabling the construction of  [ … ]
Tue, 05.01.2021       ViGeneron GmbH

ViGeneron signs global collaboration agreement for ophthalmic gene therapy development - Collaboration with Biogen to develop gene therapy for an undisclosed target to treat inherited eye disease, plus option for additional target - The companies will use ViGeneron's proprietary vgAAV technology to efficiently transduce target cells via intravi [ … ]
Tue, 05.01.2021       MorphoSys AG

Media ReleaseMorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing Authorization Application for Tafasitamab - The Swissmedic MAA seeks approval for tafasitamab in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma PLANEGG/MUNICH, Germany and MORGES, Switz [ … ]
Tue, 05.01.2021       Evotec SE

ADDING ANOTHER DRUG DISCOVERY PROJECT TO THE PORTFOLIO TRIGGERS PAYMENT TO EVOTEC Hamburg, Germany, 05 January 2021: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that the Company has received a US$ 6 m payment from Bristol Myers Squibb Company (NYSE:BMY) within the companies' iPSC-based neuroscience par [ … ]
Tue, 05.01.2021       Polyphor AG

Allschwil, Switzerland, January 5, 2021 Polyphor to take part in panel discussion on novel oncology targets at the LifeSci Partners 10th Annual Healthcare Corporate Access Event Polyphor AG (SIX: POLN) announced today that Gökhan Batur, Chief Executive Officer, will take part in a panel discussion at the LifeSci Partners 10th Annual Healthcare Co [ … ]
Tue, 05.01.2021       Implenia AG

Implenia, together with project partner HOCHTIEF, has been awarded the contract to build the 2.2-kilometre-long Altona noise protection tunnel on the A7 motorway in Hamburg. The net contract is worth a total of around EUR 580 million. Implenia will take the commercial lead on the project, working as part of a joint venture in which HOCHTIEF has the [ … ]
Tue, 05.01.2021       ENCAVIS AG

Corporate NewsENCAVIS already connected the second major project in Spain "Talayuela" to the grid on schedule Hamburg, January 5, 2021 - SDAX-listed wind and solar park operator Encavis AG (Prime Standard, ISIN: DE0006095003, Stock Exchange Initial: ECV), injected the first kilowatt hours (kwh) into the Spanish high voltage grid from "Talayuela", [ … ]
Tue, 05.01.2021       GRENKE AG

GRENKE generates new leasing business in the 2020 financial year equal to 71.2% of the previous year's level - GRENKE Group Leasing's new business in the 2020 financial year amounts to EUR 2,027.9 million, equal to 71.2% of the level in the 2019 financial year - GRENKE Group Leasing's new leasing business in Q4 2020 reaches EUR 426.7 million, eq [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 12.10.2024, Calendar Week 41, 286th day of the year, 80 days remaining until EoY.